Dr. Robert Nagourney In The News
Here are informative videos, TV segments, and articles where our founder Dr. Robert Nagourney discusses cancer biology and how we use laboratory testing to help select the most effective and least toxic drug treatment.
The Future of Cancer Research Lies Behind Us
- Robert A. Nagourney, MD
PRESS COVERAGE
Nagourney Cancer Institute Challenges “Death Sentence” Mindset in Stage 4 Pancreatic Cancer
Laboratory Method Has Proven Effective Finding Treatments for Metastatic Pancreatic Cancer, Offering Hope for Patients Facing This Deadly Cancer
​
​
January 29, 2026
Metabolic Patterns in Pancreatic Cancer Could Lead to Earlier Diagnosis
Pancreatic ductal adenocarcinoma remains a challenge to treat due to its complex biology and resistance mechanisms.
​
​“We crafted a small pilot study, taking 10 known pancreatic cancer plasma samples and comparing them with our entire database of almost 800 others,” Robert A. Nagourney, MD, the study’s lead author, explained. The samples included both cancerous and noncancerous specimens.
​
January 25, 2025
Dr. Nagourney on
CBS News
Los Angeles
In this episode of The Moss Report Podcast, Ralph W. Moss speaks with Dr. Robert Nagourney about his well-documented approach to precision oncology. Nagourney’s strategy takes a step away from genetic sequencing. By taking a biopsy of a tumor, he claims to be able to deduce what treatments will be effective for an individual. Also in this episode is a discussion about repurposed drugs for cancer treatment, including the use of Metformin.
Dr. Nagourney has appeared multiple times on "Extra" for his work with celebrity clients.
